Healthy Japanese subjects
Showing 1 - 25 of >10,000
Healthy Volunteer Study Trial in Cypress (Bemnifosbuvir (BEM))
Completed
- Healthy Volunteer Study
- Bemnifosbuvir (BEM)
-
Cypress, CaliforniaAtea Study Site
Jun 14, 2023
Healthy Subjects (Indication: Asthma) Trial in Harrow (Elarekibep, Placebo)
Not yet recruiting
- Healthy Subjects (Indication: Asthma)
- Elarekibep
- Placebo
-
Harrow, United KingdomResearch Site
Mar 20, 2023
Healthy Trial in Cypress (CD388 Injection, Saline )
Recruiting
- Healthy
- CD388 Injection
- Saline placebo
-
Cypress, CaliforniaAltasciences Clinical Los Angeles, Inc.
Jan 18, 2023
Fibrodysplasia Ossificans Progressiva Trial in Osaka (DS-6016a, Placebo)
Completed
- Fibrodysplasia Ossificans Progressiva
- DS-6016a
- Placebo
-
Osaka, JapanMedical Corporation Heishinkai OPHAC Hospital
Aug 2, 2022
Chronic Graft-versus-Host Disease (cGVHD) Trial in Randwick (AMG 592, Placebo)
Completed
- Chronic Graft-versus-Host Disease (cGVHD)
- AMG 592
- Placebo
-
Randwick, New South Wales, AustraliaResearch Site
May 23, 2023
Atopic Dermatitis Trial in Los Angeles (LEO 138559, LEO 138559 Placebo)
Completed
- Atopic Dermatitis
- LEO 138559
- LEO 138559 Placebo
-
Los Angeles, CaliforniaLEO Investigational Site
Jul 7, 2022
Healthy Japanese Subjects Trial in Nerima-ku, Shinagawa-ku (DHAPS® product, BioPS® product, Placebo)
Not yet recruiting
- Healthy Japanese Subjects
- DHAPS® product
- +2 more
-
Nerima-ku, Tokyo, Japan
- +1 more
Jul 18, 2023
Healthy Volunteers Trial (ABBV-903, Placebo for ABBV-903)
Not yet recruiting
- Healthy Volunteers
- ABBV-903
- Placebo for ABBV-903
- (no location specified)
Aug 21, 2023
Healthy Trial (BI 1015550)
Not yet recruiting
- Healthy
- BI 1015550
- (no location specified)
Nov 15, 2023
Healthy Japanese Subjects Trial in Taito-ku (Hyaluronic acid 75 mg/capsule, Hyaluronic acid 50 mg/capsule, Placebo)
Recruiting
- Healthy Japanese Subjects
- Hyaluronic acid 75 mg/capsule
- +2 more
-
Taito-ku, Tokyo, JapanUeno Asagao Clinic
Mar 26, 2023
Healthy Trial in Tokyo, Shinjuku-ku (BI 765845, Placebo)
Active, not recruiting
- Healthy
- BI 765845
- Placebo
-
Tokyo, Shinjuku-ku, JapanClinical Research Hospital Tokyo
Nov 15, 2023
Healthy Trial in Tokyo (single 1-hour IV infusion of 0.8 mg/kg recAP, single 1-hour IV infusion of 1.6 mg/kg recAP, single
Completed
- Healthy
- single 1-hour IV infusion of 0.8 mg/kg recAP
- +4 more
-
Tokyo, JapanP-One Clinic, Keikokai Medical Corporation
Mar 11, 2022
Healthy Volunteers Trial in Sagamihara (M201-A Injection, Placebo)
Completed
- Healthy Volunteers
- M201-A Injection
- Placebo
-
Sagamihara, Kanagawa, JapanClinical Trial Center, Kitasato University Hospital, THE KITASAT
Nov 28, 2021
Healthy Trial (BI 1584862, Placebo)
Not yet recruiting
- Healthy
- BI 1584862
- Placebo
- (no location specified)
Dec 1, 2023
Healthy Volunteers Trial in Las Vegas (Maribavir (400 mg), Maribavir (200 mg), Maribavir (800 mg))
Completed
- Healthy Volunteers
- Maribavir (400 mg)
- +2 more
-
Las Vegas, NevadaPPD Development, LP
Feb 5, 2022
Wilson Disease Trial in London (ALXN1840)
Completed
- Wilson Disease
-
London, United KingdomRichmond Pharmacology Ltd., St George's University of London
Nov 29, 2022
Healthy Volunteer Trial in Long Beach (BION-1301)
Recruiting
- Healthy Volunteer
-
Long Beach, CaliforniaCollaborative Neuroscience Research, LLC
Aug 17, 2022
Healthy Trial in Randwick (CSL324, Placebo)
Completed
- Healthy
- CSL324
- Placebo
-
Randwick, AustraliaScientia Clinical Research Ltd
Oct 3, 2022
Healthy Subjects Trial in Anaheim (Aprocitentan 25mg, Placebo)
Completed
- Healthy Subjects
- Aprocitentan 25mg
- Placebo
-
Anaheim, CaliforniaAnaheim Clinical Trials
Nov 22, 2022
Contrast Enhancement in Magnetic Resonance Imaging, Healthy Volunteers Trial in Fukuoka (BAY1747846, Matching )
Completed
- Contrast Enhancement in Magnetic Resonance Imaging
- Healthy Volunteers
- BAY1747846
- Matching placebo
-
Fukuoka, JapanSOUSEIKAI Fukuoka Mirai Hospital
Nov 6, 2023